지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.9
- 수록면
- 280 - 291 (12page)
- DOI
- 10.12997/jla.2024.13.3.280
이용수
초록· 키워드
오류제보하기
This review aimed to highlight the pivotal role of Mendelian randomization (MR) in advancing atherosclerotic cardiovascular disease (ASCVD) research—a field often hindered by the complexities and limitations of traditional studies. MR, which uses genetic variants as instrumental variables, provides a robust mechanism for inferring causality, offering insights untainted by the confounding factors and biases often prevalent in observational and randomized controlled trials. We explored the significant contributions of MR for elucidating the causal relationship between low-density lipoprotein cholesterol and ASCVD, and analyzed its assumptions and methodological nuances. We discussed issues surrounding instrumental variable selection, pleiotropy, and ethical considerations, in an effort to offer a balanced and insightful analysis. We highlighted the promising integration of MR with emerging technologies and global data sharing, as well as its potential to drive personalized medicine. This review provided a concise yet comprehensive journey into MR’s transformative impact on ASCVD research, offering a blend of current insights and challenges, in addition to future prospects. We aimed to serve a valuable resource for those seeking to navigate the intricate pathways of causality and intervention in ASCVD, to aid the development of enhanced understanding and targeted treatment strategies in the future.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Nutritional Therapy for Asian Patients at Risk for Atherosclerotic Cardiovascular Disease
지질·동맥경화학회지
2019 .01
-
Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization
Clinical and Molecular Hepatology
2024 .04
-
Overview of Mendelian Randomization Analysis
대한류마티스학회지
2020 .01
-
Mendelian Randomization Analysis in Observational Epidemiology
지질·동맥경화학회지
2019 .01
-
Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2018 .01
-
Lipid and Ischemic Heart Disease Revisited: Mendelian Randomization Analysis
Korean Circulation Journal
2020 .01
-
Precision Medicine and Cardiovascular Health: Insights from Mendelian Randomization Analyses
Korean Circulation Journal
2020 .01
-
The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson’s Disease: A Korean Mendelian Randomization Study
Journal Of Movement Disorders
2023 .01
-
The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers
지질·동맥경화학회지
2019 .01
-
The association between age-related hearing loss and atherosclerosis: animal and human population-based study
한국실험동물학회 학술발표대회 논문집
2019 .07
-
Association of 10-Year Atherosclerotic Cardiovascular Disease Risk Score with Carotid Intima-Media Thickness and Plaque
Korean Journal of Family Medicine
2015 .01
-
Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study
Annals of Laboratory Medicine
2023 .05
-
국내 성인환자에서 죽상동맥경화성 심혈관질환 위험도와 스타틴 처방 현황
한국임상약학회지
2021 .09
-
Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
지질·동맥경화학회지
2019 .01
-
Recent Updates of Lipoprotein(a) and Cardiovascular Disease
전남의대학술지
2021 .01
-
[Erratum]Challenges and Considerations in Sequence Variant Interpretation for Mendelian Disorders
Annals of Laboratory Medicine
2019 .01
-
무작위 배정과 배정확률에 변화를 주는 무작위 배정
Anesthesia and Pain Medicine
2017 .01
-
Mendelian Randomization Research on the Relationship Between Rheumatoid Arthritis and Systemic Lupus Erythematosus and the Risk of Autistic Spectrum Disorder
대한류마티스학회지
2022 .01
-
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
Gut and Liver
2022 .09
-
New Therapeutic Approaches to the Treatment of Dyslipidemia 2: LDL-C and Lp(a)
지질·동맥경화학회지
2023 .01
최근 본 자료
댓글(0)
0